September 20, 2013
Tokyo, Japan, September 20, 2013 -- Kyowa Hakko Kirin Co., Ltd. (President and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") announced today that NESP® Injection 5
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,630 JPY | +0.23% | +0.80% | +10.97% |
Apr. 08 | U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease | RE |
Apr. 03 | Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March | MT |
September 20, 2013
Tokyo, Japan, September 20, 2013 -- Kyowa Hakko Kirin Co., Ltd. (President and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") announced today that NESP® Injection 5
1st Jan change | Capi. | |
---|---|---|
+10.97% | 8.94B | |
+4.13% | 70.44B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+20.64% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
-0.50% | 1.64B |